917755-78-3 Usage
Chemical class
Piperidine
Contains BOC protecting group
Yes
BOC protecting group function
Protects amines and acids in organic synthesis
Contains 4-(hydroxymethyl) substituent
Yes
4-(hydroxymethyl) substituent
A hydroxymethyl group attached to the piperidine ring
Contains 4-[(4-fluorophenyl)methyl] substituent
Yes
4-[(4-fluorophenyl)methyl] substituent
A benzene ring with a fluorine atom at the para position
Potential use
Pharmaceutical research and development
Application in pharmaceuticals
Building block or intermediate for the synthesis of potential drug candidates
This compound is a member of the piperidine class and has a BOC protecting group, which is commonly used in organic synthesis to protect amines and acids. It also has a 4-(hydroxymethyl) substituent, which is a hydroxymethyl group attached to the piperidine ring, and a 4-[(4-fluorophenyl)methyl] substituent, which contains a benzene ring with a fluorine atom at the para position. This compound may be used in pharmaceutical research and development as a building block or intermediate for the synthesis of potential drug candidates.
Check Digit Verification of cas no
The CAS Registry Mumber 917755-78-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,7,5 and 5 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 917755-78:
(8*9)+(7*1)+(6*7)+(5*7)+(4*5)+(3*5)+(2*7)+(1*8)=213
213 % 10 = 3
So 917755-78-3 is a valid CAS Registry Number.
917755-78-3Relevant articles and documents
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
-
, (2015/09/22)
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
-
, (2015/09/22)
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
NOVEL BENZODIOXANE AND BENZOXAZINE DERIVATIVES USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS
-
Page/Page column 84, (2010/06/22)
The present invention relates to benzodioxane and benzoxazine derivatives that act as ligands for CC chemokine receptors, such as CCR1. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.